
Chemours Co (CC) Leadership Shake-Up and Financial Delays Cause Share Slump
The Chemours Co (CC) has announced leadership changes with Denise Dignam as Interim CEO and Matt Abbott as Interim CFO amid an internal review. Preliminary financial results for 2023 show a decrease in net sales to approximately $6.0 billion and an estimated net loss of $(225) million to $(235) million, attributed to lower volumes and significant charges. The company maintains a strong cash position and is undergoing a thorough internal review of its financial reporting practices. The delay in earnings release and filing of the Annual Report on Form 10-K has prompted the filing of a Form 12b-25 with the SEC, and investors are advised that the financial results for 2023 are preliminary and subject to change.


